Hatami Maryam, Mortazavi Mojtaba, Baseri Zahra, Khani Batool, Rahimi Mehdi, Babaei Sahar
Department of Biotechnology, Institute of Science and High Technology and Environmental Science, Graduate University of Advanced Technology, Kerman, Iran.
Evid Based Complement Alternat Med. 2023 Feb 21;2023:8056462. doi: 10.1155/2023/8056462. eCollection 2023.
Alzheimer's disease (AD) which is associated with cognitive dysfunction and memory lapse has become a health concern. Various targets and pathways have been involved in AD's progress, such as deficit of acetylcholine (ACh), oxidative stress, inflammation, -amyloid (A) deposits, and biometal dyshomeostasis. Multiple pieces of evidence indicate that stress oxidative participation in an early stage of AD and the generated ROS could enable neurodegenerative disease leading to neuronal cell death. Hence, antioxidant therapies are applied in treating AD as a beneficial strategy. This review refers to the development and use of antioxidant compounds based on natural products, hybrid designs, and synthetic compounds. The results of using these antioxidant compounds were discussed with the given examples, and future directions for the development of antioxidants were evaluated.
与认知功能障碍和记忆衰退相关的阿尔茨海默病(AD)已成为一个健康问题。AD的进展涉及多种靶点和途径,如乙酰胆碱(ACh)缺乏、氧化应激、炎症、β-淀粉样蛋白(Aβ)沉积和生物金属稳态失衡。多项证据表明,氧化应激参与AD的早期阶段,所产生的活性氧(ROS)可导致神经退行性疾病,进而导致神经元细胞死亡。因此,抗氧化疗法作为一种有益策略被应用于AD的治疗。本综述涉及基于天然产物、混合设计和合成化合物的抗氧化化合物的开发和应用。文中通过给出的实例讨论了使用这些抗氧化化合物的结果,并评估了抗氧化剂未来的发展方向。